We’re delighted to share some exciting updates to the ASO Board of Trustees, confirmed at our AGM in March 2025. Mary O’Kane has been appointed Chair, Aileen McGloin takes on the role of Deputy Chair, and Dr Sandra Isibor steps into the position of Honorary Secretary.
Each of these trustees brings a wealth of experience and a deep commitment to improving the lives of people affected by obesity. Here’s what they had to say about their new roles:
Mary O’Kane, Chair:
“I’m honoured to take on the role of Chair at such an important time for ASO. With Aileen and Sandra in their new roles, we have a strong and committed team to support the organisation’s mission and strategic direction. I look forward to working closely with our members, partners and wider stakeholders to help shape the future of obesity research and practice in the UK.”
Dr Aileen McGloin, Deputy Chair:
“It’s a privilege to support ASO in this new capacity. I’m excited to help drive our efforts to connect science, policy, and practice, and to amplify the impact of our work across the UK.”
Dr Sandra Isibor, Honorary Secretary:
“ASO plays a vital role in advancing evidence-based approaches to obesity. I’m delighted to contribute further in this role and support the governance that underpins our work.”
About our trustees
Mary O’Kane is an Honorary Consultant Dietitian in Adult Obesity at Leeds Teaching Hospitals and a Fellow of the British Dietetic Association. She also serves as Past President of the IFSO Integrated Health Section and has led national working groups on bariatric surgery guidelines, including the 2020 BOMSS update.
Dr Aileen McGloin is Director of Nutrition at Safefood, where she leads on obesity prevention and food poverty. With more than 20 years of experience in public health, research, and communications, she holds a PhD in childhood obesity.
Dr Sandra Isibor is a GP and certified Lifestyle Medicine physician with a postgraduate diploma in Obesity and Weight Management. She is an advocate for community-centred approaches to health and has been active in public campaigns to raise awareness of type 2 diabetes, particularly in ethnically minoritised communities.
We’re thrilled to have their leadership guiding ASO’s work.
